← Back to Screener
LENSAR, Inc. Common Stock (LNSR)
Price$5.55
Favorite Metrics
Price vs S&P 500 (26W)-58.87%
Price vs S&P 500 (4W)-9.15%
Market Capitalization$71.73M
All Metrics
Book Value / Share (Quarterly)$1.60
P/TBV (Annual)8.73x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)18.23%
Cash Flow / Share (Quarterly)$-1.24
Price vs S&P 500 (YTD)-53.15%
Gross Margin (TTM)46.41%
Net Profit Margin (TTM)-58.66%
EPS (TTM)$-2.90
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-2.90
Revenue Growth (5Y)17.24%
EPS (Annual)$-2.87
ROI (Annual)-165.28%
Gross Margin (Annual)46.41%
Net Profit Margin (5Y Avg)-52.93%
Cash / Share (Quarterly)$1.50
Revenue Growth QoQ (YoY)-4.22%
ROA (Last FY)-47.58%
Revenue Growth TTM (YoY)9.24%
EBITD / Share (TTM)$-2.85
ROE (5Y Avg)-61.69%
Operating Margin (TTM)-42.06%
Cash Flow / Share (Annual)$-0.20
P/B Ratio3.85x
P/B Ratio (Quarterly)5.57x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.01x
Net Interest Coverage (TTM)-14.33x
ROA (TTM)-48.11%
EPS Incl Extra (Annual)$-2.87
Current Ratio (Annual)2.80x
Quick Ratio (Quarterly)0.61x
3-Month Avg Trading Volume0.09M
52-Week Price Return-56.87%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.08
P/S Ratio (Annual)1.23x
Asset Turnover (Annual)0.81x
52-Week High$14.31
Operating Margin (5Y Avg)-41.02%
EPS Excl Extra (Annual)$-2.87
CapEx CAGR (5Y)-25.84%
26-Week Price Return-50.13%
Quick Ratio (Annual)1.97x
13-Week Price Return-50.04%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.15x
Enterprise Value$58.753
Revenue / Share Growth (5Y)-3.07%
Asset Turnover (TTM)0.82x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.05x
Pretax Margin (Annual)-58.66%
Cash / Share (Annual)$1.83
3-Month Return Std Dev84.74%
Gross Margin (5Y Avg)50.60%
Net Income / Employee (TTM)$-0
ROE (Last FY)-165.28%
EPS Basic Excl Extra (Annual)$-2.87
Receivables Turnover (TTM)9.20x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.90
Receivables Turnover (Annual)7.65x
ROI (TTM)-90.91%
P/S Ratio (TTM)1.23x
Pretax Margin (5Y Avg)-52.93%
Revenue / Share (Annual)$4.89
Tangible BV / Share (Annual)$0.99
Forward P/E1510.26x
Price vs S&P 500 (52W)-91.97%
Year-to-Date Return-49.01%
5-Day Price Return0.17%
EPS Normalized (Annual)$-2.87
ROA (5Y Avg)-31.65%
Net Profit Margin (Annual)-58.66%
Month-to-Date Return-0.50%
Cash Flow / Share (TTM)$-0.87
EBITD / Share (Annual)$-2.84
Operating Margin (Annual)-42.06%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-61.69%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-2.90
P/TBV (Quarterly)8.28x
P/B Ratio (Annual)5.77x
Inventory Turnover (TTM)1.90x
Pretax Margin (TTM)-58.66%
Book Value / Share (Annual)$1.50
Price vs S&P 500 (13W)-52.91%
Beta0.96x
Revenue / Share (TTM)$4.84
ROE (TTM)-90.91%
52-Week Low$5.33
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.29
2.29
2.29
4.29
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
LNSRLENSAR, Inc. Common Stock | 1.23x | 17.24% | 46.41% | -42.06% | $5.55 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
LENSAR Inc develops and commercializes femtosecond laser systems for cataract surgery. The company's proprietary technology platform provides surgeons with advanced imaging, simplified procedure planning, and precision capabilities to enhance surgical outcomes and procedural efficiency. LENSAR generates revenue through its core laser system and associated consumable components, creating a recurring revenue model.